Medical Wide field Imaging Systems
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2023
1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2028
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028
1.4.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue
2.5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.4.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region
3.5.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.6.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.6.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.7.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022)
5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Tesaro, Inc.
6.3.1 Tesaro, Inc. Corporation Information
6.3.2 Tesaro, Inc. Description and Business Overview
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.3.5 Tesaro, Inc. Recent Developments/Updates
6.4 Helsinn Group
6.4.1 Helsinn Group Corporation Information
6.4.2 Helsinn Group Description and Business Overview
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.4.5 Helsinn Group Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 Heron Therapeutics, Inc.
6.6.1 Heron Therapeutics, Inc. Corporation Information
6.6.2 Heron Therapeutics, Inc. Description and Business Overview
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.6.5 Heron Therapeutics, Inc. Recent Developments/Updates
6.7 Dr. Reddy's Laboratories Ltd.
6.6.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.6.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.8 Acacia Pharma
6.8.1 Acacia Pharma Corporation Information
6.8.2 Acacia Pharma Description and Business Overview
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.8.5 Acacia Pharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Otsuka Holdings Co., Ltd. Corporation Information
6.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.10.5 Otsuka Holdings Co., Ltd. Recent Developments/Updates
7 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
7.4 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
9 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
9.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
9.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
9.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
10 Global Market Forecast
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2023-2028)
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2023-2028)
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022) & (K Units)
Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
Table 20. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2017-2022)
Table 43. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2017-2022)
Table 45. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2017-2022)
Table 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Merck & Co., Inc. Corporation Information
Table 50. Merck & Co., Inc. Description and Business Overview
Table 51. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 53. Merck & Co., Inc. Recent Developments/Updates
Table 54. GlaxoSmithKline plc Corporation Information
Table 55. GlaxoSmithKline plc Description and Business Overview
Table 56. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 58. GlaxoSmithKline plc Recent Developments/Updates
Table 59. Tesaro, Inc. Corporation Information
Table 60. Tesaro, Inc. Description and Business Overview
Table 61. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 63. Tesaro, Inc. Recent Developments/Updates
Table 64. Helsinn Group Corporation Information
Table 65. Helsinn Group Description and Business Overview
Table 66. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 68. Helsinn Group Recent Developments/Updates
Table 69. F. Hoffmann-La Roche Ltd. Corporation Information
Table 70. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 71. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 73. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 74. Heron Therapeutics, Inc. Corporation Information
Table 75. Heron Therapeutics, Inc. Description and Business Overview
Table 76. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 78. Heron Therapeutics, Inc. Recent Developments/Updates
Table 79. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 80. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 81. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 83. Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
Table 84. Acacia Pharma Corporation Information
Table 85. Acacia Pharma Description and Business Overview
Table 86. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 88. Acacia Pharma Recent Developments/Updates
Table 89. Sun Pharmaceutical Industry Ltd. Corporation Information
Table 90. Sun Pharmaceutical Industry Ltd. Description and Business Overview
Table 91. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 93. Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
Table 94. Otsuka Holdings Co., Ltd. Corporation Information
Table 95. Otsuka Holdings Co., Ltd. Description and Business Overview
Table 96. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 98. Otsuka Holdings Co., Ltd. Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
Table 102. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
Table 103. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Table 104. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
Table 105. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
Table 106. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Table 107. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2021 & 2028
Figure 3. Existing Drugs Product Picture
Figure 4. Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure 5. Aloxi (Palonosetron) Product Picture
Figure 6. Emend (Aprepitant) Product Picture
Figure 7. Kytril Generic (Granisetron) Product Picture
Figure 8. Zofran Generic (Ondansetron) Product Picture
Figure 9. Pipeline Drugs Product Picture
Figure 10. SUSTOL (Granisetron Injection extended release) Product Picture
Figure 11. Rolapitant Product Picture
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2021 & 2028
Figure 13. Serotonin Receptor Antagonists
Figure 14. NK1 Receptor Antagonists
Figure 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2017-2028) & (US$ Million)
Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (2017-2028) & (K Units)
Figure 18. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturers in 2021
Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players: Market Share by Revenue in 2021
Figure 21. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)
Figure 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region in 2021
Figure 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2017-2022)
Figure 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2021
Figure 26. U.S. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Taiwan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Indonesia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Thailand Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Malaysia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Philippines Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Vietnam Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. U.A.E Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2017-2022)
Figure 51. Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 52. Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 53. Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co., Inc. GlaxoSmithKline plc Tesaro, Inc. Helsinn Group F. Hoffmann-La Roche Ltd. Heron Therapeutics, Inc. Dr. Reddy's Laboratories Ltd. Acacia Pharma Sun Pharmaceutical Industry Ltd. Otsuka Holdings Co., Ltd.